News Search Results
Jun 30, 2025, 08:30 ET Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer's disease trial and interim analysis timeline
information on the durability of Xanamem's benefits." About Actinogen Medical Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. There is a strong
More news about: Actinogen Medical Limited
Jun 30, 2025, 08:00 ET Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
June 30, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase
More news about: Intensity Therapeutics Inc.
Jun 30, 2025, 08:00 ET Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
June 30, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Jun 30, 2025, 08:00 ET Avant Technologies and JV Partner, Ainnova, Prepare for Key FDA Milestone with Next Week's Pre-Submission Meeting
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Jun 30, 2025, 07:45 ET ARTAN Bio Partners with Syenex VivoCell Platform for Precision in vivo Delivery of Next-Generation Codon Suppressors for Aging
ARTAN Bio, a community-backed biotechnology company developing therapeutics to reverse epigenetic changes associated with aging and age-related disease, and
More news about: Syenex
Jun 30, 2025, 07:00 ET Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy
acquisition of the Company or the exclusive license of pelareorep. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jun 29, 2025, 16:43 ET Sealless Pumps Market to Reach $8.2 Billion by 2032, Growing at a CAGR of 10.6% from 2025, Says Meticulous Research®
pumps, and varying industry standards across different applications. However, significant opportunities exist in emerging pharmaceutical and biotechnology markets, development of smart pump technologies and AI-powered monitoring systems, expansion in developing markets with growing industrial infrastructure,
More news about: Meticulous Market Research Private Limited
Jun 27, 2025, 19:04 ET HEPA Filters Market to Reach $5.8 Billion by 2032, Growing at a CAGR of 7.9% from 2025, Says Meticulous Research®
adoption of HEPA filters in residential sectors for indoor air purification. The market's expansion is fueled by the expansion of healthcare and biotechnology sectors, growth in smart homes and connected air filtration systems, and the development of hybrid filtration technologies combining HEPA with activated
More news about: Meticulous Market Research Pvt. Ltd
Jun 27, 2025, 18:25 ET Freeze Drying Equipment Market to Surge from USD 4.9 Billion to USD 8.4 Billion by 2032 - Meticulous Research®
sustained demand for freeze-dried food products across diverse consumer segments. Pharmaceutical & Biotechnology Drives Premium Growth The pharmaceutical and biotechnology sector exhibits the highest growth potential through increasing demand for lyophilized drug products, vaccine
More news about: Meticulous Market Research Pvt. Ltd
Jun 27, 2025, 13:41 ET Kalorama Highlights Key Trends and Breakthroughs in Blood Typing Market in New Report
division of Science and Medicine Group, is a leading provider of healthcare market research, delivering actionable intelligence to diagnostics, biotechnology, medical device, and pharmaceutical companies worldwide. Media Contact:Name: Alisa AlvichTitle:
More news about: Kalorama Information
Jun 27, 2025, 12:00 ET Frost & Sullivan Recognizes Leading Organizations with Prestigious 2025 Best Practices Awards
airsysnorthamerica.com Novotech2025 Global Biotechnology Contract Research Organization Company of the Year AwardNovotech has redefined the biotech CRO landscape with a client-centric approach
More news about: Frost & Sullivan
Jun 27, 2025, 12:00 ET Frost & Sullivan Recognizes Leading Organizations with Prestigious 2025 Best Practices Awards
airsysnorthamerica.com Novotech2025 Global Biotechnology Contract Research Organization Company of the Year AwardNovotech has redefined the biotech CRO landscape with a client-centric approach
More news about: Frost & Sullivan
Jun 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jun 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jun 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jun 27, 2025, 09:00 ET Debut Named to TIME's List of the TIME100 Most Influential Companies 2025
"This global recognition affirms Debut's pioneering achievements in innovating higher-performing products and ingredients in beauty using AI and biotechnology," said Joshua Britton, PhD, Founder and CEO of Debut. "I am incredibly proud and honored to receive this accolade
More news about: Debut
Jun 27, 2025, 09:00 ET MEET THE UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE BOARD OF VISITORS
exceptional roster of new board members, representing a unique range of backgrounds and professional expertise in finance, law, pharmaceuticals, biotechnology and public policy to complement our current members," said
More news about: University of Maryland School of Medicine
Jun 27, 2025, 06:49 ET Regenics Appoints Brynjólfur Gísli Eyjólfsson as Chair of the Board
Investments (IS Haf Fjárfestingar slhf.) is a private equity fund managed by Iceland Funds with a focus on sustainable investments in seafood, marine biotechnology, and the blue economy. The fund is the largest investor in Nordic Blue hf., an Icelandic investment company with significant holdings in Regenics.
More news about: Regenics AS
Jun 26, 2025, 20:05 ET Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July
support our clients rely on to advance the next generation of cell and gene therapies." About SynthegoSynthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health.
More news about: Synthego
Jun 26, 2025, 18:17 ET Faruqi & Faruqi Reminds Fortrea Holdings Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 - FTRE
from buy to hold. Among other things, the Jefferies Report cited perceived weaknesses in the Company's business model as a CRO amid pressure on biotechnology funding and suggested that the cost savings Fortrea expects to achieve by exiting the TSAs are "not as material as [o]ne [m]ight think," stating
More news about: Faruqi & Faruqi, LLP
Jun 26, 2025, 16:15 ET Origin Agritech Announced Financial Results for the Six Months Ended March 31, 2025
These agreements encompass comprehensive biotechnology services focusing on BBL2-2 transgenic applications, molecular marker-based variety improvement, gene editing technology implementation, and corn mutant library applications.Biotechnology Advancements: The
More news about: Origin Agritech Limited
Jun 26, 2025, 13:44 ET Pharmaceutical Cold Storage Market to Reach $34.5 Billion by 2035, Growing at a CAGR of 6.9% from 2025, Says Meticulous Research®
Cell/Gene Therapy Storage, Blood & Plasma Storage, Hospital Storage, Pharmacy Distribution, Research Storage), End-User (Pharmaceutical & Biotechnology Companies, CROs, Third-Party Logistics Providers, Hospitals & Healthcare Providers, Research Institutes, Pharmacies & Distributors), &
More news about: Meticulous Market Research Pvt Ltd.
Jun 26, 2025, 13:33 ET Precision Fermentation Ingredients Market to Explode from USD 1.2 Billion to USD 38.02 Billion by 2032 - Meticulous Research®
stands at the forefront of the alternative protein revolution, addressing critical challenges in sustainable food production through innovative biotechnology solutions. This cutting-edge technology uses genetically modified microorganisms including yeast, algae, filamentous fungi, and bacteria to produce
More news about: Meticulous Market Research Pvt Ltd.
Jun 26, 2025, 12:01 ET Global Cancer Immunotherapy Market Projected to Reach $247 Billion by 2029, Driven by 11.4% CAGR
accelerate the development and availability of new treatments. Technological Progress: Advances in genomics, artificial intelligence, and biotechnology are transforming the field of immunotherapy. These technologies enable more targeted, personalized, and efficient treatments, expanding the range
More news about: BCC Research LLC
Jun 26, 2025, 11:50 ET eSIM Market Size is Set to Achieve USD 17.98 Billion by 2031, With CAGR of 18.7% | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners